Cystic fibrosis drug company to re-engage with HSE on price of Orkambi

Vertex has responded to calls from the HSE with a view to re-engage on the pricing of cystic fibrosis drug Orkambi.

Cystic fibrosis drug company to re-engage with HSE on price of Orkambi
Wed, 07 Dec, 2016 - 18:40

Vertex has responded to calls from the HSE with a view to re-engage on the pricing of cystic fibrosis drug Orkambi.

In a statement this evening, Minister for Health Simon Harris said he is pleased to learn that Vertex has responded to the HSE.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Paediatrician doctor examining a young female patient sitting on her mothers lap wearing masks. 'Parents forced to take State to court for services and even diagnoses for their children'
Watch: Cork Circus Factory workshop for members of the Crann Centre  Watch: Cork Circus Factory workshop for members of the Crann Centre 
Sir Jeffrey Donaldson court case Ex-DUP leader Jeffrey Donaldson to renounce knighthood after sex abuse convictions
CourtsCystic FibrosisOrkambi
<p>Following the announcement of plans to transition Synge Street CBS to a gaelcholáiste in September 2024, ASTI president Donal Cremin said students, parents, and teachers had been 'ignored, bypassed and disregarded'. File picture: Sam Boal/Collins</p>

'At least they'll have someone to converse with': Only two pupils enrolled in new gaelcholáiste

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited